At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution may contribute to the development of more effective management options that are tailored to individual genetic profiles – this is termed ‘precision medicine’.
ESMO 2014: Tumour evolution and precision medicine
20th March 2015
Oncology
